These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
460 related articles for article (PubMed ID: 31428232)
21. Extracellular vesicles as tools and targets in therapy for diseases. Kumar MA; Baba SK; Sadida HQ; Marzooqi SA; Jerobin J; Altemani FH; Algehainy N; Alanazi MA; Abou-Samra AB; Kumar R; Al-Shabeeb Akil AS; Macha MA; Mir R; Bhat AA Signal Transduct Target Ther; 2024 Feb; 9(1):27. PubMed ID: 38311623 [TBL] [Abstract][Full Text] [Related]
22. Extracellular Vesicles as Novel Delivery Tools for Cancer Treatment. Erkan EP; Saydam O Curr Cancer Drug Targets; 2016; 16(1):34-42. PubMed ID: 26412464 [TBL] [Abstract][Full Text] [Related]
23. A call for the standardised reporting of factors affecting the exogenous loading of extracellular vesicles with therapeutic cargos. Rankin-Turner S; Vader P; O'Driscoll L; Giebel B; Heaney LM; Davies OG Adv Drug Deliv Rev; 2021 Jun; 173():479-491. PubMed ID: 33862168 [TBL] [Abstract][Full Text] [Related]
24. The Challenges and Possibilities of Extracellular Vesicles as Therapeutic Vehicles. Melling GE; Carollo E; Conlon R; Simpson JC; Carter DRF Eur J Pharm Biopharm; 2019 Nov; 144():50-56. PubMed ID: 31419585 [TBL] [Abstract][Full Text] [Related]
25. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System. Shahjin F; Chand S; Yelamanchili SV J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884 [TBL] [Abstract][Full Text] [Related]
26. Extracellular vesicles as emerging targets in cancer: Recent development from bench to bedside. Wu K; Xing F; Wu SY; Watabe K Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):538-563. PubMed ID: 29054476 [TBL] [Abstract][Full Text] [Related]
27. Extracellular vesicles as biomarkers and therapeutic targets for cancer. Urabe F; Kosaka N; Ito K; Kimura T; Egawa S; Ochiya T Am J Physiol Cell Physiol; 2020 Jan; 318(1):C29-C39. PubMed ID: 31693397 [TBL] [Abstract][Full Text] [Related]
28. Engineered extracellular vesicles and their mimetics for cancer immunotherapy. Liu C; Wang Y; Li L; He D; Chi J; Li Q; Wu Y; Zhao Y; Zhang S; Wang L; Fan Z; Liao Y J Control Release; 2022 Sep; 349():679-698. PubMed ID: 35878728 [TBL] [Abstract][Full Text] [Related]
29. Extracellular vesicles as a novel approach for breast cancer therapeutics. Lee Y; Graham P; Li Y Cancer Lett; 2023 Feb; 555():216036. PubMed ID: 36521658 [TBL] [Abstract][Full Text] [Related]
30. Subpopulations of extracellular vesicles and their therapeutic potential. Lässer C; Jang SC; Lötvall J Mol Aspects Med; 2018 Apr; 60():1-14. PubMed ID: 29432782 [TBL] [Abstract][Full Text] [Related]
31. Message in a bubble: the translational potential of extracellular vesicles. Alqurashi H; Alsharief M; Perciato ML; Raven B; Ren K; Lambert DW J Physiol; 2023 Nov; 601(22):4895-4905. PubMed ID: 37795936 [TBL] [Abstract][Full Text] [Related]
32. Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment: Recent advances, current obstacles, and challenges for clinical translation. Pirisinu M; Pham TC; Zhang DX; Hong TN; Nguyen LT; Le MT Semin Cancer Biol; 2022 May; 80():340-355. PubMed ID: 32977006 [TBL] [Abstract][Full Text] [Related]
33. Role of tumor‑derived extracellular vesicles in cancer progression and their clinical applications (Review). Qiao F; Pan P; Yan J; Sun J; Zong Y; Wu Z; Lu X; Chen N; Mi R; Ma Y; Ji Y Int J Oncol; 2019 May; 54(5):1525-1533. PubMed ID: 30864674 [TBL] [Abstract][Full Text] [Related]
34. Extracellular vesicle-based Nanotherapeutics: Emerging frontiers in anti-inflammatory therapy. Tang TT; Wang B; Lv LL; Liu BC Theranostics; 2020; 10(18):8111-8129. PubMed ID: 32724461 [TBL] [Abstract][Full Text] [Related]
35. The Role of Extracellular Vesicles in the Pathogenesis and Treatment of Autoimmune Disorders. Lu M; DiBernardo E; Parks E; Fox H; Zheng SY; Wayne E Front Immunol; 2021; 12():566299. PubMed ID: 33732229 [TBL] [Abstract][Full Text] [Related]
36. Extracellular vesicles in infectious diseases - importance and perspectives. Vydrář D; Snopková S; Husa P Epidemiol Mikrobiol Imunol; 2023; 72(3):164-171. PubMed ID: 37871990 [TBL] [Abstract][Full Text] [Related]
37. Extracellular vesicles for drug delivery. Vader P; Mol EA; Pasterkamp G; Schiffelers RM Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656 [TBL] [Abstract][Full Text] [Related]
38. Extracellular Vesicles in Cardiovascular Theranostics. Bei Y; Das S; Rodosthenous RS; Holvoet P; Vanhaverbeke M; Monteiro MC; Monteiro VVS; Radosinska J; Bartekova M; Jansen F; Li Q; Rajasingh J; Xiao J Theranostics; 2017; 7(17):4168-4182. PubMed ID: 29158817 [TBL] [Abstract][Full Text] [Related]
39. Extracellular Vesicles as Potential Therapeutics for Inflammatory Diseases. Hwang HS; Kim H; Han G; Lee JW; Kim K; Kwon IC; Yang Y; Kim SH Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34067503 [TBL] [Abstract][Full Text] [Related]
40. Analysis and Biomedical Applications of Functional Cargo in Extracellular Vesicles. Qian F; Huang Z; Zhong H; Lei Q; Ai Y; Xie Z; Zhang T; Jiang B; Zhu W; Sheng Y; Hu J; Brinker CJ ACS Nano; 2022 Dec; 16(12):19980-20001. PubMed ID: 36475625 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]